Critical Analysis of Immune Checkpoint Inhibitor Immunotoxicity Management

Volume: 3, Issue: 1, Pages: 84 - 94
Published: Jan 1, 2021
Abstract
Immune checkpoint inhibitors are a revolution in cancer treatment, having a better toxicity profile than chemotherapy. However, many mechanisms and management of immune-related adverse events are still unknown, and guidelines are a crucial tool to take clinical decisions. However, even the most recent guidelines lack information about alternative treatments for steroid-refractory immune-related adverse events, safety in special populations,...
Paper Details
Title
Critical Analysis of Immune Checkpoint Inhibitor Immunotoxicity Management
Published Date
Jan 1, 2021
Volume
3
Issue
1
Pages
84 - 94
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.